ArticleFrontiers in pharmacology2021

Dehydrocorydaline Protects Against Sepsis-Induced Myocardial Injury Through Modulating the TRAF6/NF-κB Pathway.

Yadong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.